DRUG · Mapped RxNorm record
bicalutamide
Normalized identity: bicalutamideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer
NCT00002651
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
goserelin acetate
Normalized identity: goserelin acetateView linked drug · Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
clinical observation
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedSWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
bicalutamideDRUG · verified · RxNorm: bicalutamide
goserelin acetateDRUG · verified · RxNorm: goserelin acetate
clinical observationOTHER
Sponsors & collaborators
SWOG Cancer Research Networklead sponsor
National Cancer Institute (NCI)collaborator
NCIC Clinical Trials Groupcollaborator
Cancer and Leukemia Group Bcollaborator
Eastern Cooperative Oncology Groupcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00002651 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.